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Abstract
Background: A decrease in the compliance of the arterial system, 
termed  arterial  stiffness,  results  in  increased  cardiac  workload. 
Several studies have shown that arterial stiffness is increased in 
individuals with type 2 diabetes. Also, insulin resistance is gener-
ally considered to be of major importance in the pathophysiology 
of type 2 diabetes mellitus given that glucose intolerance and in-
sulin resistance precede the development of overt diabetes, these 
factors would be associated with arterial stiffness. This study was to 
evaluate the state of aortic elasticity in prediabetic adults in relation 
to insulin resistance.
Methods:  A case-control study was performed. A total of 113 con-
secutive  adults  with  prediabetes  were  enrolled  for  the  study, 
32 adults had insulin resistance (group A) and 81 had insulin sen-
sitive (group B). Forty-five healthy (with normal fasting glucose) 
adults matched for age and gender were considered as control. All 
were subjected to full medical history and clinical examination in-
cluding blood pressure and body mass index. Biochemical studies 
including lipids profile, fasting glucose and homeostasis model as-
sessment of insulin resistance (HOMA IR) test. Echocardiographic 
studies were done for assessment of the aortic stiffness index.
Results:  Significant increase in mean aortic stiffness index was 
seen in group A than group B. Stiffness was correlated with insu-
lin resistance and the correlation appeared to be independent of 
glucose tolerance status and obesity. Similar correlations were ob-
served with age, triglycerides and waist circumference.
Conclusions:  Prediabetic subjects have an aortic stiffness which 
represent pattern of cardiovascular risk factors. These changes are 
predominantly  observed  in  prediabetic  subjects  with  increased 
HOMA IR and visceral obesity independent of glucose levels.
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Introduction
Diabetes mellitus, hypertension, dyslipidemia, obesity, and 
aging are associated with high risk of cardiovascular disease 
(CVD) as well as other clinical conditions [1]. The mecha-
nisms through which cardiovascular risk is increased are par-
tially understood. A decrease in the compliance of the central 
arterial system, termed arterial stiffness, results in increased 
cardiac workload [2]. As arterial changes can be detected be-
fore the appearance of clinically apparent vascular disease, 
arterial stiffness may act either as a marker for the develop-
ment of future atherosclerotic disease, or may be more di-
rectly involved in the process of atherosclerosis [3].
A number of factors are believed to be responsible for 
arterial  stiffness.  These  include  decreased  elastin  and  in-
creased collagen in the arterial wall, abnormal endothelial 
regulation of arterial smooth muscle tone, and the accumula-
tion of advanced glycosylation end products (AGE) leading 
to protein cross-linking [4-6]. 
Several studies have shown that arterial stiffness is in-
creased in individuals with type 2 diabetes. Also, insulin re-
sistance is generally considered to be of major importance in 
the pathophysiology of type 2 diabetes mellitus [7]. 
Given  that  glucose  intolerance  and  insulin  resistance 
precede  the  development  of  overt  diabetes,  these  factors 
would be associated with arterial stiffness. To investigate 
this hypothesis, the current study was undertaken to evaluate 
the state of aortic elasticity in prediabetic adults in relation 
to insulin resistance.
 
Patients and Methods
Patient selection
A case-control study was performed. A total of 113 consecu-
tive adults with prediabetes were enrolled for the study. All 
were recruited from the outpatient diabetes and general med-
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icine clinics of Suez Canal University Hospital from May 
2007 to October 2009. Thirty-two adults had insulin resis-
tance (group A) and 81 had insulin sensitive (group B). For-
ty-five healthy (with normal fasting glucose) adults matched 
for age and gender were considered as a control group.  
Exclusion criteria included the following, hypertension, 
diabetes mellitus, chronic kidney disease, CVD, severe obe-
sity (body mass index > 40 kg/m2), heavy smokers, and aged 
adults (over 60 years old).
All groups were subjected to full medical history and 
clinical examination including blood pressure (BP), body 
mass  index  (BMI),  systemic  examination,  biochemical 
and  echocardiographic  studies,  anthropometric  measures 
(weight in kilogram, height in centimeter, BMI, waist cir-
cumference).  BMI was calculated as weight/height2 (kg/
m2) and was used as an estimate of overall adiposity. Nor-
mal weight, overweight, and obesity were defined as a BMI 
less than 25, 25 to 29.9, and 30 or higher, respectively [8]. 
Waist circumference, a validated estimate of visceral adipos-
ity, was measured to the nearest 0.5 cm. Central obesity is 
defined as waist circumference > 102 cm in males and > 88 
cm in females [9]. 
Diabetes was diagnosed according to world health or-
ganization (WHO) criteria.  Blood is drawn after fasting for 
eight hours. A fasting blood sugar level below 100 mg/dL is 
considered normal. A fasting blood sugar level between 100 
and 126 mg/dL confirms the presence of prediabetes, and 
more than 126 mg/dL confirms the presence of diabetes in 
two separate occasions [10]. Homeostasis model assessment 
of insulin resistance (HOMA IR) was used as a measure of 
insulin resistance. It was assessed according to the level of 
fasting glucose and insulin which were measured with a dex-
tran-charcoal  radioimmunoassay.  Serum  intact  pro-insulin 
was measured by using a highly specific, 2-site monoclonal 
antibody-based immunoradiometric assay [10, 11]. The for-
mula for the HOMA IR model follows: HOMA IR = (Fasting 
insulin mU/mL X Fasting glucose mmol/L) / 22.5.
Subjects were divided by their insulin resistance status 
at baseline (HOMA IR above and below median of 3.0) to 
insulin resistant and insulin sensitive respectively. The me-
dian was based on the overall nondiabetic control group at 
baseline.
Aortic stiffness index (β) as a characteristic of aortic elas-
ticity was evaluated from ascending aortic diameter. Aortic 
stiffness index (β) was evaluated by means of transthoracic 
echocardiography by use of the formula: β = ln (SBP/DBP) / 
(ΔD/ DD), where SBP and DBP are the systolic and diastolic 
blood pressures, DD is the diastolic aortic diameter, ΔD is 
the pulsatile change in aortic diameter (systolic diameter mi-
nus diastolic diameter) and ‘ln’ is the natural logarithm [12].
Variable Control
Group
N = 45
Prediabetic adults (Case )  N = 113 P value
All
N = 113
Group A
N = 32
Group B
N = 81
P* P** P***
Age 
SBP
DBP
BMI
Waist circumference
Total lipids
Triglycerides
FBS
HOMA IR
Aortic stiffness index
1.4  + 7.8
121.1 + 8.2
72.9 + 7.6
28.6 +  5.7
100.3 + 16.3
501.1 + 42.9
186.8 + 15.6
83.1 +  7.2
2.9 + 0.4
2.8 + 1.1
45.1 + 6.2
122.2 + 9.2
73.9 + 6.9
28.4 + 5.2
103 + 17..2
491 + 31.9
187.7+ 12.4
114.5 + 4.8
3.7 + 2.5
5.5 + 3.1
44.9 + 7.1
120.9 + 7.9
74.9 + 6.5
28. 5+ 5.2
107 + 11.6
479 + 26.7
187 + 14.2
114.8 + 4.6
7.5 + 0.7
10.2 + 1.2
45.3 + 5.9
120.1 + 9.5
73.5 + 7.1
28.4 + 5.1
1025 + 18.2
499.7 + 36.4
188.5 + 11.9
115.7 + 4.9
2.2 + 0.4
3.6 + 0.7
n.s
n.s
n.s
n.s
n.s
n.s
n.s
< 0.01
< 0.01
< 0.001
n.s
n.s
n.s
n.s
n.s
n.s
n.s
< 0.01
n.s
n.s
n.s
n.s
n.s
n.s
n.s
n.s
n.s
n.s
n.s
n.s
44.4 + 7.8
Table 1. Clinical and Biochemical Studies of Both Case  and Control Groups
Group A, prediabetic adult with insulin resistance. Group B, prediabetic adult with insulin sensitive. BMI, body mass index. SBP, systolic 
blood pressure. DBP, diastolic BP N=number of cases. n.s, non significant. FBS, fasting blood glucose. P*, comparison between group A and 
control. P**, comparison between group B and control. P***, comparison between all prediabetic adults and control group.
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Ethical consideration
Informed consent was obtained from all the adults. The aim 
and the value of the work were explained in a simplified 
manner for them. There was no harm inflicted on them. On 
the contrary all had benefits of the follow-up and the final 
results of the study. The study was approved by the ethics 
committee of faculty of medicine, Suez Canal University.
Statistical analysis   
Data were presented in terms of mean and standard deviation 
(SD) of the mean, and percentages. Statistical analysis was 
carried out by a computer program (SPSS Ver. 11). Student-t 
test and correlation tests were used to evaluate the results. 
P value was set at less than 0.05 for statistically significant 
results and less than 0.0001 for highly significant results.
 
Results
Baseline characteristics of 113 (60 males and 53 females) 
prediabetic adults, mean age 43.1 years, with and without 
insulin resistance versus 45 control (24 males and 21 fe-
males), mean age 44.4 years are  shown in Table 1, 36.2% 
of the prediabetic adults had insulin resistance, 63.8% had 
insulin sensitive. No significant differences were observed 
between both prediabetic adult and control groups regard-
ing BMI, waist circumference, blood pressure, and plasma 
lipids. Regarding aortic stiffness index, no significant differ-
ence was observed between either all prediabetic cases or 
group B and control group, while high significant differences 
were observed between group A and both group B and con-
trol (Fig 1). Except waist circumference all the mentioned 
parameters were nearly similar in both male and female pre-
diabetic adults. 
Correlation between aortic stiffness index and different 
variables of insulin resistant prediabetic group (group A) is 
shown in Table 2. There was statistically significant coef-
ficient correlation with HOMA IR, waist circumference, tri-
glycerides and age. No correlation was observed with fasting 
glucose, BMI, blood pressure and total lipids. Similarly, no 
correlations were found with overall prediabetic population 
variables.
Discussion
  
Type 2 diabetes mellitus is associated with a marked increase 
in CVD. Increased risk factors for CVD before the onset of 
type 2 diabetes have been shown in several populations [1, 
10, 13]. It is not known whether the increased atherogenicity 
of the prediabetic state is primarily due to increased insulin 
resistance or impaired blood glucose [14].
There has been much recent interest in the relationship 
between arterial stiffness and CVD. Pulse pressure,  pulse 
wave velocity, and echographic surrogate measures of arte-
rial stiffness, indicate that arterial stiffness increases both 
with age and in certain disease states that are themselves 
associated with increased cardiovascular risk, including hy-
pertension, diabetes mellitus, hyperlipidemia, obesity, and 
end-stage renal failure [15-18].
However, the state of arterial elasticity in prediabetes 
has received little attention. We therefore studied prediabetic 
Figure 1. Mean Values of Aortic Stiffness Index in Case and Control Groups.
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normotensive adults in whom the prevalence of insulin re-
sistance and impaired glucose tolerance is high, to test the 
hypotheses that insulin resistance is associated with arterial 
stiffness and that this relationship is dependent or indepen-
dent of glucose tolerance status.
The main finding of current study is that, insulin resis-
tance is associated with arterial stiffness and that the asso-
ciation appears to be independent of glucose tolerance status 
and obesity. Hyperglycemia has been shown to lead to the 
formation of advanced glycosylation endproducts (AGEs). 
Therefore, it has been suggested that individuals with pre-
diabetes may have increased central arterial stiffness due to 
prolonged exposure to elevated glucose levels [4, 6]. Results 
from the present study did not identify an increase in central 
arterial stiffness among individuals with insulin sensitive 
prediabetes. Furthermore, no correlation was found between 
arterial stiffness and fasting glucose measurements. Our data 
suggest that insulin resistance may be more important in the 
development of central arterial stiffness than accumulation 
of AGEs.
The  mechanism  underlying  the  relationship  between 
insulin  resistance  and  arterial  stiffness  is  unknown,  and 
current cross-sectional study cannot identify the causative 
factor. Studies have shown that insulin-resistant states are 
associated with decreased endothelium-dependent vasodi-
lation [19]. In addition, insulin has been shown to induce 
vascular smooth muscle proliferation and migration in cell 
culture [20]. 
Previous studies have shown that visceral fat in young 
healthy individuals and older adults is associated with in-
creased central arterial stiffness [18, 21, 22]. The present 
study confirms this association. In agreement with a recent 
study by Sabio et al [16], we observed that abdominal adi-
posity  as  measured  by  waist  circumference  was  strongly 
and adversely associated with aortic stiffness, whereas body 
mass index as a measure of general adiposity was not. In 
addition, the present study found that insulin resistance ap-
pears to be more strongly associated with arterial stiffness 
than with measures of obesity. These results suggest that the 
obesity-arterial  stiffness  relationship  may  be  mediated  in 
part through increasing insulin resistance. In general, adipo-
cytes, in particular from visceral abdominal regions, produce 
several bioactive peptides which in turn impact on vascular 
structure and function [23, 24].
However, increased distending pressure tends to reduce 
the elasticity of a given arterial segment through the recruit-
ment of collagen fibers [25, 26]. Nevertheless, in our study, 
as all subjects were normotensive, such the association was 
not held.
We should point out that the total lipids had insignificant 
correlation with aortic stiffness. When the components of the 
lipids were considered separately, aortic stiffness showed di-
rect associations only with triglycerides
In current study, age was an independent predictor of 
aortic stiffness. It is known that different arterial segments 
respond differently to aging. Aorta, an elastic artery, loses 
its compliance with advancing age, whereas compliance in 
the peripheral, predominantly muscular, arteries appears less 
closely related to age [15, 27, 28].
In conclusion, we have shown that prediabetic subjects 
have an aortic stiffness which represent pattern of cardiovas-
cular risk factors, and these changes are predominantly ob-
served in prediabetic subjects with increased HOMA IR and 
visceral obesity. As the aortic elasticity changes in the predi-
abetic state are limited to subjects with insulin resistance, the 
use of insulin-sensitizing agents to prevent diabetes could 
have a beneficial effect on CVD. None of the studied pre 
diabetic adult had cardiac complications. The data of the cur-
rent study report that, as changes can be detected before the 
appearance of clinically apparent vascular disease, arterial 
stiffness may act as a marker for the development of future 
CVD. It is likely that over the next few years measurement 
of arterial stiffness will become an increasingly important 
part of the process of risk assessment, and may possibly also 
improve the monitoring of therapy [29]. Additional studies 
will be needed to assess the effect of an improvement in in-
sulin sensitivity to decrease arterial stiffness. 
It is important to note several limitations in this study 
design. First, the sample size was relatively small. Second, 
this study enrolled a relatively population of older individu-
als carefully screened to exclude diabetes and hypertension. 
Further research will be needed to confirm whether these 
results generalize to middle-aged, more insulin-sensitive in-
dividuals and those with hypertension through a large com-
munity based study.
Variable r value        P value
Age 0.81           < 0.01                          
Total cholesterol              0.13             n.s   
Low density lipoprotein    0.24              n.s                            
Triglyceride 0.75            < 0.01                          
HOMA IR                         0.91           < 0.001                         
Waist circumference         0.86           < 0.01                           
Total lipids                        0.4            n.s
Systolic blood pressure       0.33          n.s
Diastolic blood pressure           0.36          n.s
High densitylipoprotein    0.21           n.s
Fasting blood glucose        0.19           n.s
Body mass index               0.16           n.s
Table 2. Correlation Coefficient Between Aortic Stiff-
ness Index and Different Variables in Group A
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